Price disclosure changes

Fact sheets are now available explaining the changes to the price disclosure arrangements tabled in the Federal Government’s 2015 Access and Sustainability package.

The changes which mostly relate to products on the F2 Formulary include:

  • Price disclosure reductions to component ingredient drugs to be applied to F2 combination items where this results in a lower price than direct application of price disclosure